Summary
Tuberculosis treatment strategies generally involve a combination of antitubercular drugs which need to be taken for atleast 6-9 months to completely cure the infection. The treatment regimen for tuberculosis typically consists of an intensive phase of 2 months where 4 drugs - isoniazid, rifampicin, pyrazinamide and ethambutol are given and a continuation phase of 4-7 months where isoniazid and rifampicin are continued. For drug resistant strains of M.tuberculosis, the treatment regimen is modified accordingly based on the drug susceptibility testing. Several factors can impact the treatment outcomes in tuberculosis. Patient related factors such as treatment adherence, alcohol abuse, malnutrition etc can lead to treatment failure or relapse.Disease related factors such as multi-drug resistance, extensive disease with multiple lobes involved or presence of cavities also pose a challenge for treatment success. Lack of awareness about the disease and stigma associated with it can also interfere with treatment compliance. Strategies to improve treatment outcomes include directly observed therapy or DOTS where a healthcare worker observes the patient swallowing the anti-TB drugs. This ensures treatment compliance and adherence. Patient counseling and education about the importance of completing the full course of treatment is also helpful. Nutritional and social support in the form of food supplements and incentives can improve outcomes especially in resource poor settings.Newer diagnostic techniques which provide rapid drug susceptibility results help in timely modification of treatment regimens for drug resistant cases. Use of DOTS and patient education/counselling have been shown to significantly improve cure rates and reduce default rates in multiple studies. Providing financial and food incentives, especially in low income groups can help reduce treatment default by removing barriers to access. Measures to reduce stigma around the disease through public awareness campaigns are also important for improving case detection and treatment compliance. In summary, a multi-pronged approach which addresses patient, disease, and healthcare related factors is needed to improve treatment outcomes for tuberculosis. Adequate treatment, treatment compliance, nutritional support and public health measures all play a role in achieving high cure rates and preventing transmission of this infectious disease. Regular monitoring of treatment outcomes and drug resistance patterns assists in timely modification of strategies for effective control of tuberculosis.
We conducted a review of studies on alcohol and TB outcomes. Alcohol increased odds of poor outcomes for DS and MDR-TB.
Published By:
E. Ragan - The International Journal of Tuberculosis and Lung Disease
2020
Cited By:
51
Successful outcome was 92.5%.Appropriate strategies should improve outcome.
Published By:
Assefa Tola - Tuberculosis Research and Treatment
2019
Cited By:
43
Diabetes mellitus worsens tuberculosis treatment outcomes. TB-DM patients had higher odds of death and relapse according to analysis of 56,122 TB-DM and 243,035 TB patients across 64 studies.
Published By:
P. Huangfu - The International Journal of Tuberculosis and Lung Disease
2019
Cited By:
83
Smokers who contract tuberculosis tend to have poorer treatment outcomes than non-smokers according to this review of 21 studies.
Published By:
E. Wang - The International Journal of Tuberculosis and Lung Disease
2020
Cited By:
31
TB patients in Ghana had high adherence and knowledge, though few knew night sweats were a symptom. Males adhered more.
Published By:
Eyram Dogah - Tuberculosis Research and Treatment
2021
Cited By:
3
HIV-positive adults between 2009-2015 with TB showed improved TB treatment from 67-76% and 97% ART initiation; mortality remained >15% mostly late presenters.
Published By:
J. Musaazi - The International Journal of Tuberculosis and Lung Disease
2019
Cited By:
11
A regimen must always include a core drug with the highest activity, along with companion drugs. Maximum 100 characters
Published By:
A. Deun - The International Journal of Tuberculosis and Lung Disease
2018
Cited By:
65
A study assessed factors associated with presciption of treatment for latent TB infection to close contacts of pulmonary TB cases in Catalonia.
Published By:
Á. Domínguez - Vaccines
2023
Cited By:
0
As estimated from meta-analysis, non-adherence rates for TB treatment in Ethiopia remain too high at 10% overall to achieve target success rates; implementing effective patient retention and DOTS are critical.
Published By:
H. Tola - The International Journal of Tuberculosis and Lung Disease
2019
Cited By:
14
Tuberculosis is a fatal infectious disease caused by Mycobacterium tuberculosis. Current treatments have issues like prolonged course, high pill burden and poor compliance, leading to drug resistance.
Published By:
M. Nasiruddin - Tuberculosis Research and Treatment
2017
Cited By:
124